| |
| |
|
| Insider
Information: |
Hyde Joseph R III |
| Relationship: |
Director |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,411,298 |
|
|
Indirect Shares
|
2,672,247 |
|
|
| Direct
Value |
$235,016,621 |
|
|
|
Indirect Value
|
$6,500,627 |
|
|
| Total
Shares |
7,083,545 |
|
|
| Total
Value |
$241,517,248 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fedex Corp |
FDX |
Director |
2009-04-29 |
132,000 |
2008-11-03 |
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director, 10% Owner |
2019-01-02 |
4,207,368 |
2019-01-02 |
2,670,247 |
Premium* |
|
|
Autozone Inc |
AZO |
Director |
2018-01-01 |
71,930 |
2018-01-01 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
178 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-08-03 |
4 |
B |
$9.28 |
$93,391 |
I/I |
10,000 |
8,200 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2005-09-30 |
4 |
A |
$9.31 |
$5,000 |
D/D |
537 |
8,006,855 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2005-07-01 |
4 |
A |
$9.94 |
$5,000 |
D/D |
503 |
8,006,318 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-01-27 |
4 |
B |
$10.35 |
$572,093 |
D/D |
55,264 |
7,515,957 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-07-01 |
4 |
A |
$10.46 |
$5,000 |
D/D |
478 |
7,943,789 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-04-01 |
4 |
A |
$10.58 |
$9,000 |
D/D |
851 |
7,642,301 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-01-29 |
4 |
B |
$10.74 |
$274,995 |
D/D |
25,600 |
7,591,557 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-01-28 |
4 |
B |
$10.84 |
$541,885 |
D/D |
50,000 |
7,565,957 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2006-04-01 |
4 |
A |
$10.92 |
$5,000 |
D/D |
458 |
7,442,461 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-01-30 |
4 |
B |
$10.94 |
$422,110 |
D/D |
38,570 |
7,630,127 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2018-01-02 |
4 |
A |
$11.46 |
$15,625 |
D/D |
1,363 |
1,734,893 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-10 |
4 |
B |
$11.51 |
$138,463 |
I/I |
12,000 |
58,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-14 |
4 |
B |
$11.57 |
$163,296 |
I/I |
14,000 |
72,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-08 |
4 |
B |
$11.83 |
$142,255 |
I/I |
12,000 |
34,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-09 |
4 |
B |
$11.85 |
$142,905 |
I/I |
12,000 |
46,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-11-01 |
5 |
A |
$12.00 |
$728,280 |
D/D |
60,690 |
8,005,266 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-11-01 |
5 |
D |
$12.00 |
$728,280 |
I/I |
(60,690) |
232,223 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-07 |
4 |
B |
$12.01 |
$144,620 |
I/I |
12,000 |
22,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-10-01 |
4 |
A |
$12.02 |
$5,000 |
D/D |
416 |
7,944,205 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2004-06-04 |
4 |
B |
$12.11 |
$122,182 |
I/I |
10,000 |
10,000 |
2.25 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2009-10-01 |
4 |
A |
$12.80 |
$9,000 |
D/D |
703 |
7,709,180 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-03-11 |
4 |
A |
$13.27 |
$517,335 |
I/I |
38,716 |
715,716 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2005-01-01 |
4 |
A |
$13.49 |
$5,000 |
D/D |
371 |
7,944,576 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-12-01 |
4 |
B |
$13.50 |
$250,261 |
D/D |
18,544 |
7,753,589 |
3.92 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • • |
2008-12-02 |
4 |
B |
$13.72 |
$90,579 |
D/D |
6,600 |
7,760,189 |
3.92 |
- |
|
178 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
